Covalent Bruton tyrosine kinase inhibitors (BTKis) have improved CLL management, but discontinuation due to adverse events ...

Lisocabtagene maraleucel (liso-cel) shows high response rates in heavily pretreated patients with relapsed or refractory chronic lymphocytic leukemia (CLL), with a CR/CRu rate of 60% and ORR of 83.3%.

Global Response to the Burden of Cancer: The WHO Approach The last several years have seen an explosion of novel therapies for chronic lymphocytic leukemia (CLL). These include the antibody ...

In this video, Matthew S. Davids, MD, said data from the BRUIN-313 trial supports front-line approval of pirtobrutinib in patients with previously untreated chronic lymphocytic leukemia or small ...

Kristie L. Kahl: In simple terms, can you explain what chronic lymphocytic is? Dr. Susan O’Brien: It’s a leukemia, which by definition means it's in the blood and in the bone marrow because inside ...

Leukemia is a form of cancer that affects cells in the blood and bone marrow. It’s classified based on how fast the cancer grows (acute vs. chronic) and the kinds of cells affected (lymphocytic vs.

Monoclonal B-cell lymphocytosis is when your body produces an elevated number of identical B cells. In some cases, it can develop into chronic lymphocytic leukemia. Monoclonal B-cell lymphocytosis ...

Remission is good news. It means most or all signs of your cancer are gone. In some types of cancer, remission may turn into a lasting cure. But when you have chronic lymphocytic leukemia (CLL), your ...

About Secura Bio, Inc. Secura Bio is an integrated, commercial-stage pharmaceutical company dedicated to the worldwide development and commercialization of impactful oncology therapies for physicians ...